Delivery Order SPE2DB20D3104-SPE2DB25FV7F5

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,583.31 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,797.21 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,492.54 delivery order contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,085.32 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,437.66 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a specialty medication, with a completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,860.53 delivery order contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 19, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,432.89 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,944.22 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,001.32, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with Firm Fixed Price pricing and has an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,238.27 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV7F5
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,033.39 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. No subcontractor information is provided.

Generated 8/17/25, 1:00 AM